# A Study of Iguratimod in Combination With Tofacitinib in RA Patients

> **NCT06945666** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jie Chang** · enrollment: 200 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA

## Interventions

- **DRUG:** Combined therapy of Iguratimod and tofacitinib

## Key facts

- **NCT ID:** NCT06945666
- **Lead sponsor:** Jie Chang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06945666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06945666, "A Study of Iguratimod in Combination With Tofacitinib in RA Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06945666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*